GlassScriptPhysician profile
Ziqiang Wu
NPI 1609874817
$3,476.96
in general payments reported to CMS, 2019-2025
21 companies · $287 in 2025
The $287 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,094 · 2020: $313 · 2021: $235 · 2022: $581 · 2023: $474 · 2024: $493 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,254.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $990.09 | 2019-2025 | Hydrus Microstent, Rocklatan, Clareon |
| Genentech USA, INC. | $658.24 | 2019-2025 | Vabysmo, Lucentis |
| Novartis Pharmaceuticals Corporation | $550.05 | 2019-2023 | |
| Aerie Pharmaceuticals, INC. | $204.75 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $142.11 | 2024 | |
| Genentech, INC. | $105.16 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $103.93 | 2019 | |
| Hoffmann-La Roche Limited | $99.00 | 2019 | |
| Astellas Pharma US INC | $94.71 | 2025 | Izervay |
| Ivantis, INC | $92.02 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $63.00 | 2021-2022 | |
| Biotissue Holdings INC. | $61.11 | 2022-2024 | |
| Sight Sciences, INC. | $58.00 | 2021-2025 | Omni Surgical System |
| Bausch & Lomb Americas INC. | $48.91 | 2023-2024 | Xiidra, Miebo |
| Dompe US, INC. | $45.00 | 2023-2024 | Oxervate |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $40.67 | 2024 | |
| Ocular Therapeutix, INC. | $30.01 | 2022 | |
| Glaukos Corporation | $28.89 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Harrow Eye, LLC | $23.59 | 2025 | Vevye |
| Oyster Point Pharma, INC. | $19.70 | 2023 | Tyrvaya |
| Rxsight INC | $18.02 | 2023 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ziqiang Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.